- Tytuł:
- Additional hepatic Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
- Autorzy:
- Źródło:
- BMC gastroenterology [BMC Gastroenterol] 2018 Jun 15; Vol. 18 (1), pp. 84. Date of Electronic Publication: 2018 Jun 15.
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article
- MeSH Terms:
-
Antineoplastic Agents/*therapeutic use
Embolization, Therapeutic/*methods
Holmium/*therapeutic use
Liver Neoplasms/*therapy
Neuroendocrine Tumors/*therapy
Octreotide/*analogs & derivatives
Organometallic Compounds/*therapeutic use
Radioisotopes/*therapeutic useRadiopharmaceuticals /*therapeutic use
Biomarkers, Tumor ; Combined Modality Therapy ; Holmium/adverse effects ; Humans ; Liver Neoplasms/diagnostic imaging ; Liver Neoplasms/secondary ; Neoplasm Metastasis ; Neuroendocrine Tumors/diagnostic imaging ; Neuroendocrine Tumors/secondary ; Octreotide/therapeutic use ; Quality of Life ; Radioisotopes/adverse effects ;Radiopharmaceuticals /adverse effects ; Remission Induction ; Survival Analysis
Czasopismo naukowe